Scientific Programme

Sunday, June 21, 2009

16:00-19:00

Registration

Monday, June 22, 2009

09:00-10:35

Epidemiology and Natural History of PSC
Chairs:   Erik Schrumpf, Norway
              Ulrich Beuers, The Netherlands

09:00

Welcome/introduction
Erik Schrumpf, Norway

09:10

Update on the epidemiology of PSC
Paul Angulo, USA

09:30    

PSC in children
Dennis Black, USA

09:55 PSC in low-prevalence areas
Carlo Selmi, Italy
10:15 Small-duct PSC
Einar Björnsson, Sweden
10:35-11:15 Coffee Break and Poster Viewing
11:15-13:00        

Pathogenesis of PSC I
Chairs:   Michael Trauner, Austria
              Pietro Invernizzi, Italy

11:15 Pathogenesis of PSC
Michael P. Manns, Germany
11:45 Genetic epidemiology of PSC
Tom H. Karlsen, Norway
12:10 Aberrant lymphocyte homing in PSC – only a hypothesis?
David Adams, UK
12:30 Pathogenesis of IBD in PSC
Arthur Kaser, Austria
13:00-14:00

Lunch and Poster Viewing

14:00-15:30

Pathogenesis of PSC II
Chairs:   David Adams, UK
              Steve Pereira, UK

14:00

Relevance of mouse models in PSC
Peter Fickert, Austria

14:20

Role of bile acids in inflammation and carcinogenesis
Michael Trauner, Austria

14:50

Role of cholangiocytes in PSC
Marco Marzioni, Italy

15:10 Pathogenesis of bile duct fibrosis and liver cirrhosis in PSC
David Brenner, USA
15:30-16:00 Coffee Break and Poster Viewing
16:00-17:25

Overlap Syndrome and Autoimmunity in PSC
Chairs:   Kirsten Muri Boberg, Norway
              George Webster, UK

16:00

Innate immune responses in PSC
Christopher Bowlus, USA

16:20 Pathogenetic importance of autoantibodies in PSC
Ulrich Spengler, Germany
16:45

PSC overlap syndromes
Giorgina Mieli-Vergani, UK

17:05 Lessons learnt from IgG4-associated cholangitis
Ulrich Beuers, The Netherlands
18:00-19:30 Reception and Tour at Oslo City Hall
   

Tuesday, June 23, 2009

08:30-10:45

Malignancies in PSC
Chairs:   Gregory Gores, USA 
              Ragnhild Lothe, Norway

08:30

Cholangiocarcinogenesis
Gregory Gores, USA

09:00

Relevance of NKG2D in inflammatory carcinogenesis
Yenan Bryceson, Sweden

09:25

Surveillance and early diagnosis of cholangiocarcinoma
Kirsten Muri Boberg, Norway

09:55

Colorectal malignancies in PSC
Annika Bergquist, Sweden

10:15

Liver transplantation in cholangiocarcinoma
Julie Heimbach, USA 

10:45-11:15 Coffee Break and Poster Viewing
11:15-13:30

Clinical Practice
Chairs:   Peter Jansen, The Netherlands
              Martti Färkkilä, Finland

11:15

Ursodeoxycholic acid therapy in PSC – who benefits?
Keith Lindor, USA

11:35

Endpoints and design of future PSC trials
Roger Chapman, UK

12:00

Discussion: Endoscopic treatment in PSC – a critical appraisal
Adolf Stiehl, Germany
Lars Aabakken, Norway

12:30

Timing and results of liver transplantation in PSC
Kristian Bjøro, Norway

12:50

Pathogenesis, diagnosis and prognosis of recurrent PSC
Andrew K. Burroughs, UK

13:15 Concluding remarks
Erik Schrumpf,
Norway
 13:30-14:30  Lunch